FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:53-54 July 4, 1996 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

For decades it has been known that oral contraceptive drugs are one of the most effective forms of birth control. Despite their clear and substantial benefits, concern has remained about the short-term and long-term risks associated with these agents. The latter include an increased risk of venous thromboembolism, myocardial infarction, and stroke, both ischemic and hemorrhagic. Since the amount of estrogen in oral-contraceptive preparations has been thought to be chiefly responsible for these risks, in recent years newer, low-estrogen oral contraceptives (containing less than 50 µg) have been developed and become widely used.

Of the long-term risks, stroke is one . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Jousilahti, P., Tuomilehto, J., Rastenyte, D., Vartiainen, E. (2003). Headache and the Risk of Stroke: A Prospective Observational Cohort Study Among 35 056 Finnish Men and Women. Arch Intern Med 163: 1058-1062 [Abstract] [Full Text]  
• Cuadrado, M.J., Khamashta, M.A., Hughes, G.R.V. (2000). Migraine and stroke in young women. QJM 93: 317-318 [Full Text]  
• Chang, C L, Donaghy, M., Poulter, N. (1999). Migraine and stroke in young women: case-control study. BMJ 318: 13-18 [Abstract] [Full Text]